Prognostic value of liver fibrotic markers in patients with heart failure

Back

ESC Professional Premium Access

Prognostic value of liver fibrotic markers in patients with heart failure

Session: Emerging evidence for biomarkers in heart failure

Topic: Biomarkers

Speaker: Doctor A. Tada (Rochester, US)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Atsushi Tada

Mayo Clinic, Rochester (United States of America)

0 follower

4 more presentations in this session

Cardiac Troponin T level is not a predictor of mortality in patients with post-cardiotomy shock supported with venoarterial extracorporeal membrane oxygenation.

Speaker: Doctor M. Celinska-Spodar (Warsaw, PL)

The prognostic role of clinical features and biomarkers in patients hospitalized with cardiorenal syndromes

Speaker: Doctor P. Theofilis (Athens, GR)

Prognostic significance of growth differentiation factor-15 across the BMI spectrum in patients with chronic heart failure: Insights from the SUPPORT trial

Speaker: Doctor K. Teramoto (Osaka, JP)

Continuous measurement of percutaneous oxygen saturation during 6-minute walk test is useful for stratification of the prognostic risk in patients with heart failure

Speaker: Doctor I. Sunayama (Nishinomiya, JP)

Access the full session

Emerging evidence for biomarkers in heart failure

Speakers: Doctor A. Tada, Doctor M. Celinska-Spodar, Doctor P. Theofilis, Doctor K. Teramoto, Doctor I. Sunayama

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources